Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 292 | 1,187 | 987 | 515 | 33 |
| Gross Profit | 292 | 1,187 | 987 | 515 | 33 |
| Operating Expenses | 8,029 | 8,611 | 9,539 | 21,541 | 6,267 |
| Operating Income | -7,737 | -7,424 | -8,552 | -21,026 | -6,234 |
| Other Income | -242 | -342 | -258 | 24 | 744 |
| Pre-tax Income | -7,979 | -7,766 | -8,810 | -21,002 | -5,490 |
| Net Income Continuous | -7,979 | -7,766 | -8,810 | -21,002 | -5,490 |
| Net Income | $-7,979 | $-7,766 | $-8,810 | $-21,002 | $-5,490 |
| EPS Basic Total Ops | -0.45 | -0.44 | -0.57 | -1.94 | -0.49 |
| EPS Basic Continuous Ops | -0.45 | -0.44 | -0.58 | -1.69 | -0.49 |
| EPS Diluted Total Ops | -0.45 | -0.44 | -0.57 | -1.94 | -0.49 |
| EPS Diluted Continuous Ops | -0.45 | -0.44 | -0.58 | -1.69 | -0.49 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.44 | -0.92 | N/A | N/A |
| EBITDA(a) | $-7,606 | $-7,293 | $-8,395 | $-20,932 | $-6,141 |